Danaher Co. (NYSE:DHR)’s stock price reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $147.76 and last traded at $146.90, with a volume of 83317 shares traded. The stock had previously closed at $146.69.
A number of research analysts have recently commented on DHR shares. UBS Group raised their price target on Danaher from $158.00 to $165.00 and gave the company a “buy” rating in a report on Monday. Wolfe Research set a $154.00 price objective on shares of Danaher and gave the stock a “buy” rating in a report on Friday, October 25th. ValuEngine lowered shares of Danaher from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Needham & Company LLC lowered their target price on shares of Danaher from $155.00 to $152.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. Finally, Stifel Nicolaus reissued a “hold” rating and set a $150.00 target price on shares of Danaher in a research note on Thursday, November 14th. Five research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $147.53.
The company has a debt-to-equity ratio of 0.52, a current ratio of 3.43 and a quick ratio of 3.09. The business has a fifty day moving average of $139.57 and a 200-day moving average of $139.66. The stock has a market capitalization of $104.85 billion, a price-to-earnings ratio of 32.41, a price-to-earnings-growth ratio of 2.45 and a beta of 0.92.
Large investors have recently modified their holdings of the stock. Howe & Rusling Inc. lifted its holdings in shares of Danaher by 116.3% during the third quarter. Howe & Rusling Inc. now owns 186 shares of the conglomerate’s stock valued at $27,000 after purchasing an additional 100 shares during the last quarter. Next Capital Management LLC purchased a new position in shares of Danaher in the second quarter worth approximately $31,000. Litman Gregory Asset Management LLC purchased a new position in shares of Danaher in the second quarter worth approximately $33,000. Altshuler Shaham Ltd increased its position in shares of Danaher by 59.3% in the second quarter. Altshuler Shaham Ltd now owns 239 shares of the conglomerate’s stock worth $34,000 after acquiring an additional 89 shares in the last quarter. Finally, Pinnacle Bank raised its holdings in shares of Danaher by 52.3% during the third quarter. Pinnacle Bank now owns 262 shares of the conglomerate’s stock valued at $38,000 after acquiring an additional 90 shares during the period. Hedge funds and other institutional investors own 78.10% of the company’s stock.
About Danaher (NYSE:DHR)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Featured Article: Understanding Relative Strength Index
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.